TRIM52 and hepatocellular carcinoma: TRIM52 is upregulated in hepatitis B virus‐associated hepatocellular carcinoma, and the upregulation of HBV X protein induces the activation of NF‐κB signalling to increase the expression of TRIM52 in HepG2 cells, which in turn promotes the proliferation of HepG2 cells.33